Mono-ADP-Ribose antibody | AbD33205

anti Mono-ADP-Ribose

Product Type
Monoclonal Antibody
Clone
AbD33205
Isotype
IgG
Specificity
Mono-ADP-Ribose

Product Code Applications Pack Size List Price Your Price Qty
HCA355
Datasheet Datasheet Datasheet
SDS Safety Datasheet SDS
IF WB 0.1 mg loader
List Price Your Price
loader
Search for Batch Specific Datasheets

Anti mono-ADP-ribose antibody, clone AbD33205, recognizes mono-adenosine diphosphate (ADP)-ribosylation. ADP-ribosylation is a reversible post-translational modification that occurs in multicellular organisms as well as some lower unicellular eukaryotes, but is absent in prokaryotes and yeast (Bürkle 2005). ADP ribosylation has been shown to play critical roles in many physiological and pathological processes, including bacterial pathogenesis and signaling and metabolism to control chromatin-related processes including transcription and DNA repair (Bonfiglio et al. 2020, Bütepage et al. 2015).



Members of the ADP-ribosyltransferase (ART) superfamily of proteins including the poly(ADP-ribose) polymerases (PARPs) subfamily, catalyze the transfer of ADP-ribose from nicotinamide adenine dinucleotide (NAD+) onto substrate protein via N-, O-, or S-glycosidic linkages. These transferases are able to transfer a single ADP-ribose residue to their substrate proteins, in a process known as mono-ADP-ribosylation (Bütepage et al. 2015).

This clone AbD33205 is a mono-selective ADP-ribose antibody which was generated using an H3S10ADPr peptide as the antigen. This clone is specific for mono-ADPr and recognizes Ser-mono-ADPr. Another mono-ADPr antibody (HCA354, AbD33204) also specifically recognizes mono-ADP-ribose, however it has a preference for mono-ADP-riboses other than Ser-mono-ADPr, with a preference for ubiquitin Arg-ADPr and mono-ADPr catalyzed by other PARPs.

Anti mono-ADP-ribose antibody, clone AbD33205, has been used in immunofluorescence staining of H2O2-treated U2OS cells to showed strong nuclear staining, relating to HPF1 and PARP1, but not PARP2. This staining was abolished upon treatment with the PARP inhibitors (Bonfiglio et al. 2020).

Target Species
Protein/peptide tag
Product Form
Human/Rabbit IgG chimera (rabbit CH2 and CH3) antibody selected from the HuCAL® phage display library and expressed in a human cell line. This antibody is supplied as a liquid.
Preparation
Purified recombinant IgG prepared by affinity chromatography on Protein A from a mammalian cell line
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.01% Thiomersal
Carrier Free
Yes
Immunogen
ARTKQTARKS(ADPr)TGGKAC
Approx. Protein Concentrations
Total protein concentration 0.5 mg/ml
Regulatory
For research purposes only
Guarantee
12 months from date of despatch
Acknowledgements
This product and/or its use is covered by claims of U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc. See bio-rad.com/en-us/trademarks for details.

This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. Should this product contain a precipitate we recommend microcentrifugation before use.

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
Immunofluorescence 1/100
Western Blotting 2 ug/ml
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.

Antibody Characterization Reference

  1. Bonfiglio, J.J. et al. (2020) An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation.
    Cell. 183 (4): 1086-1102.e23. Cell. 183 (4): 1086-1102.e23.